Summit Securities Group’s Medicines Co MDCO Stock Holding History

Summit Securities Group’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,000	Closed	-$467K	–	556
2019 Q3	$350K	Buy	+7,000	New	+$279K	0.03%	236
2014 Q2	–	Sell	-3,000	Closed	-$85K	–	683
2014 Q1	$85K	Buy	+3,000	New	+$99.3K	0.05%	151

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Summit Securities Group's MDCO Position: Q4 2019 in Review

Summit Securities Group sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 7,000 shares — an estimated $467K sold.

Summit Securities Group first reported a position in MDCO in Q1 2014 and held it in 2 quarters. The position peaked at $350K in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

Summit Securities Group reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
Summit Securities Group sold 7,000 Medicines Co shares in Q4 2019, an estimated $467K.
Summit Securities Group first reported a position in Medicines Co in Q1 2014 and held it in 2 quarters.
Summit Securities Group's Medicines Co position peaked at $350K in Q3 2019.
284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Summit Securities Group's 13F filing for Q4 2019, filed 13 Jan 2020.